vs
Caledonia Mining Corp Plc(CMCL)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Caledonia Mining Corp Plc的1.6倍($75.5M vs $46.9M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 13.8%),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 17.1%)
霍赫希尔德矿业是总部位于秘鲁利马、在英国伦敦设有企业办事处的领先银金矿开采企业,业务覆盖北美、中美及南美地区。公司在伦敦证券交易所上市,是富时250指数成分股,大股东为秘鲁企业家爱德华多·霍赫希尔德。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
CMCL vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$46.9M
营收增速更快
PBYI
高出13.9%
13.8%
两年增速更快
PBYI
近两年复合增速
17.1%
损益表 — Q3 FY2024 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $46.9M | $75.5M |
| 净利润 | $3.3M | — |
| 毛利率 | 41.2% | 69.3% |
| 营业利润率 | 18.6% | 22.7% |
| 净利率 | 7.0% | — |
| 营收同比 | 13.8% | 27.7% |
| 净利润同比 | -33.3% | — |
| 每股收益(稀释后) | $0.13 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CMCL
PBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | — | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $46.9M | $80.5M | ||
| Q2 24 | $50.1M | $47.1M | ||
| Q1 24 | $38.5M | $43.8M |
净利润
CMCL
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $3.3M | $20.3M | ||
| Q2 24 | $10.2M | $-4.5M | ||
| Q1 24 | $2.1M | $-4.8M |
毛利率
CMCL
PBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | 41.2% | 63.9% | ||
| Q2 24 | 45.8% | 77.4% | ||
| Q1 24 | 35.9% | 75.5% |
营业利润率
CMCL
PBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | 18.6% | 27.4% | ||
| Q2 24 | 32.2% | -4.6% | ||
| Q1 24 | 13.8% | -5.3% |
净利率
CMCL
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.0% | 25.2% | ||
| Q2 24 | 20.3% | -9.6% | ||
| Q1 24 | 5.4% | -11.0% |
每股收益(稀释后)
CMCL
PBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $0.13 | $0.41 | ||
| Q2 24 | $0.42 | $-0.09 | ||
| Q1 24 | $0.07 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $7.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $231.0M | $130.3M |
| 总资产 | $339.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
CMCL
PBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | $7.2M | $96.7M | ||
| Q2 24 | $15.4M | $96.8M | ||
| Q1 24 | $1.8M | $107.2M |
总债务
CMCL
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
CMCL
PBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | $231.0M | $71.1M | ||
| Q2 24 | $231.1M | $48.5M | ||
| Q1 24 | $220.3M | $51.0M |
总资产
CMCL
PBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | — | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | $339.7M | $220.7M | ||
| Q2 24 | $338.5M | $205.0M | ||
| Q1 24 | $321.8M | $214.1M |
负债/权益比
CMCL
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势,按日历期对齐
经营现金流
CMCL
PBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $4.6M | $11.0M | ||
| Q2 24 | $19.1M | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流
CMCL
PBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率
CMCL
PBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度
CMCL
PBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率
CMCL
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.40× | 0.54× | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图